Affiliation:
1. Federal Research Centre of Nutrition and Biotechnology, 109240 Moscow, Russia
Abstract
Adequate experimental animal models play an important role in an objective assessment of the effectiveness of medicines and functional foods enriched with biologically active substances. The aim of our study was a comparative assessment of the effect of consumption of 1 or 2% cholesterol with and without regular (two times a week), moderate running exercise on the main biomarkers of lipid and cholesterol metabolism, as well as the intestinal microbiota of male Wistar rats. In experimental rats, a response of 39 indicators (body weight, food consumption, serum biomarkers, liver composition, and changes in intestinal microbiota) was revealed. Total serum cholesterol level increased 1.8 times in animals consuming cholesterol with a simultaneous increase in low-density lipoprotein cholesterol (2 times) and decrease in high-density lipoprotein cholesterol (1.3 times) levels compared to the control animals. These animals had 1.3 times increased liver weight, almost 5 times increased triglycerides level, and more than 6 times increased cholesterol content. There was a tendency towards a decrease in triglycerides levels against the background of running exercise. The consumption of cholesterol led to a predominance of the Bacteroides family, due to a decrease in F. prausnitzii (1.2 times) and bifidobacteria (1.3 times), as well as an increase in Escherichia family (1.2 times). The running exercise did not lead to the complete normalization of microbiota.
Funder
Russian Science Foundation
Reference60 articles.
1. Obesity Phenotypes. Diabetes. and Cardiovascular Diseases;Tchernof;Circ. Res.,2020
2. Obesity as a predictor of metabolic disorders and a target for personalized interventions;Babenko;Ross. Zhurnal Pers. Meditsiny,2021
3. Probiotic-fermented blueberry pomace alleviates obesity and hyperlipidemia in high-fat diet C57BL/6J mice;Chai;Food Res. Int.,2022
4. Contemporary medical. device. and surgical therapies for obesity in adults;Perdomo;Lancet,2023
5. Epidemiology and management of hyperlipidemia;Karr;Am. J. Manag. Care,2017